A role of hydrogen peroxide producing commensal bacteria present in colon of adolescents with inflammatory bowel disease in perpetuation of the inflammatory process

Journal of Physiology and Pharmacology

Volumn 60, Issue SUPPL.6, 2009, Pages 49-54

  Strus, M ^a   Gosiewski, T ^a   Fyderek, K ^b   Wedrychowicz, A ^b   Kowalska Duplaga, K ^b   Kochan, P ^a   Adamski, P ^c   Heczko, Piotr B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c INSTITUTE OF NATURE CONSERVATION   (Poland)

Author keywords

Aerobic bacteria; Crohn's disease; Hydrogen peroxide; Inflammatory bowel disease; Lactobacillus; Ulcerative colitis

Indexed keywords

HYDROGEN PEROXIDE; LIPOPOLYSACCHARIDE;

ADOLESCENT; AEROBIC BACTERIUM; ARTICLE; COLON; ENTERITIS; ENTEROBACTERIACEAE; FECES; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; OCCULT BLOOD; PATHOLOGY; POLAND;

ADOLESCENT; BACTERIA, AEROBIC; COLON; ENTEROBACTERIACEAE; FECES; HUMANS; HYDROGEN PEROXIDE; INFLAMMATORY BOWEL DISEASES; LIPOPOLYSACCHARIDES; OCCULT BLOOD; POLAND;

EID: 77954491621     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fantini MC, Monteleone G, Macdonald TT. New players in the cytokine orchestra of inflammatory bowel disease. Inflamm Bowel Dis 2007; 13: 1419-1423.
2. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006; 55: 1141-1149.
3. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002; 37: 1034-1041.
4. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005; 43: 3380-3389.
5. Swidsinski A, Loening-Baucke V, Theissig F, et al. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut 2007; 56: 343-350.
6. Nathan CF. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J Clin Invest 1987; 80: 1550-1560.
7. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-852.
8. Denning TL, Takaishi H, Crowe SE, Boldogh I, Jevnikar A, Ernst PB. Oxidative stress induces the expression of Fas and Fas ligand and apoptosis in murine intestinal epithelial cells. Free Radic Biol Med 2002; 33: 1641-1650.
9. Pacelli R, Wink DA, Cook JA, et al. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J Exp Med 1995; 182: 1469-1479.
10. Sokal R, Rohlt FJ. Biometry. San Francisco, Freeman, 1982.
11. Ferguson GA. Statistical Analyses In Psychology And Education, New York, McGraw-Hill, 1989.
12. Sartor RB, Cromartie WJ, Powell DW, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985; 89: 587-595.
13. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785.
14. Weersma RK, van Dullemen HM, van der Steege G, Nolte IM, Kleibeuker JH, Dijkstra G. Inflammatory bowel disease and genetics. Aliment Pharmacol Ther 2007; 26: 57-65.
15. Kruidenier L, Kuiper I, Van Duijn W, et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003; 201: 17-27.
16. Heczko PB, Strus M, Kochan P. Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J Physiol Pharmacol 2006; 57: 5-12.
17. Mach T. Clinical usefulness of probiotics in inflammatory bowel diseases. J Physiol Pharmacol 2006; 57: 23-33.
18. Zwolinska-Wcislo M, Brzozowski T, Budak A, et al. Effect of Candida colonization on human ulcerative colitis and the healing of inflammatory changes of the colon in the experimental model of colitis ulcerosa. J Physiol Pharmacol. 2009; 60(1): 107-18.
19. Strus M, Uhlig H, Powrie F, et al. A role of bacteria in inflammatory bowel disease evoked in animal models. Gastroenterol Pol 2005; 12: 15-20.
20. Seksik P, Rigottier-Gois L, Gramet G, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 2003; 52: 237-242.
21. Griffiths E. Iron in biological systems. In Iron And Infection, JJ Bullen, E Griffiths (eds). Chichester, Wiley, 1987, pp. 1-25.
22. Law D, Wilkie KM, Freeman R, Gould FK. The iron uptake mechanisms of enteropathogenic Escherichia coli: the use of haem and haemoglobin during growth in an iron-limited environment. J Med Microbiol 1992; 37: 15-21.
23. Mietzner TA, Morse SA. The role of iron-binding proteins in the survival of pathogenic bacteria. Annu Rev Nutr 1994; 14: 471-493.
24. Caradonna L, Amati L, Magrone T, Pellegrino NM, Jirillo E, Caccavo D. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 2000; 6: 205-214.
25. Kane TD, Alexander JW, Johannigman JA. The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients. Ann Surg 1998; 227: 1-9.
26. Bernhard AE, Field KG. A PCR assay to discriminate human and ruminant feces on the basis of host differences in Bacteroides-Prevotella genes encoding 16S rRNA. Appl Environ Microbiol 2000; 66: 4571-4574.
27. Tilsala-Timisjarvi A, Alatossava T. Development of oligonucleotide primers from the 16S-23S rRNA intergenic sequences for identifying different dairy and probiotic lactic acid bacteria by PCR. Int J Food Microbiol 1997; 35: 49-56.
28. Walter J, Tannock GW, Tilsala-Timisjarvi A, et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and speciesspecific PCR primers. Appl Environ Microbiol 2000; 66: 297-303.